CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-06 | Leuthner Brian A President and CEO | Sale | −1,500 | $9.52 | $14K | 246,979 |
| 2017-02-03 | Leuthner Brian A President and CEO | Sale | −1,500 | $9.69 | $15K | 248,479 |
| 2017-02-02 | Leuthner Brian A President and CEO | Sale | −1,500 | $9.61 | $14K | 249,979 |
| 2017-02-01 | Leuthner Brian A President and CEO | Sale | −1,500 | $9.38 | $14K | 251,479 |
| 2017-01-23 | Macdonald R. Loch Chief Scientific Officer | Exercise or conversion | +25,000 | $2.04 | $51K | 595,602 |
| 2017-01-23 | Macdonald R. Loch Chief Scientific Officer | Exercise or conversion · Stock Option (right To Purchase) | −25,000 | 75,504 | ||
| 2016-12-01 | Leuthner Brian A President and CEO | Sale | −7,500 | $11.60 | $87K | 252,979 |
| 2016-11-01 | BRENNAN DANIEL Chief Operating Officer | Grant or award · Stock Option (right To Purchase) | +150,000 | $10.09 | $1.5M | 150,000 |
| 2016-10-03 | Leuthner Brian A President and CEO | Sale | −7,500 | $10.25 | $77K | 260,479 |
| 2016-08-08 | MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary | Purchase | +143 | $9.43 | $1K | 10,000 |
| 2016-08-05 | MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary | Purchase | +9,857 | $9.48 | $93K | 9,857 |
| 2016-08-01 | Leuthner Brian A President and CEO | Sale | −7,500 | $9.54 | $72K | 267,979 |
| 2016-06-21 | HEALY JAMES Director | Grant or award · Stock Option (right To Purchase) | +15,000 | 15,000 | ||
| 2016-06-21 | BLECH ISAAC Director | Grant or award · Stock Option (right To Purchase) | +15,000 | 15,000 | ||
| 2016-06-21 | Conti Kurt G Director | Grant or award · Stock Option (right To Purchase) | +15,000 | 15,000 | ||
| 2016-06-21 | Spiegel Robert J. Director | Grant or award · Stock Option (right To Purchase) | +15,000 | 15,000 | ||
| 2016-06-21 | BARER SOL J Director | Grant or award · Stock Option (right To Purchase) | +30,000 | 30,000 | ||
| 2016-06-21 | LOUGHLIN JAMES J Director | Grant or award · Stock Option (right To Purchase) | +15,000 | 15,000 | ||
| 2016-06-21 | Ratcliffe Liam Director | Grant or award · Stock Option (right to purchase) | +30,000 | 30,000 | ||
| 2016-06-16 | Vaish Renu V.P., Global Reg. Affairs | Exercise or conversion | +5,000 | $5.13 | $26K | 5,350 |
Page 13 of 18 · 346 trades